Cyclophosphamide Videos

2004 Rare Neuroimmunologic Disorders Symposium Acute Therapies B. Weinshenker, MD Corticosteroids, Plasma Exchange, Cyclophosphamide

FDA APPROVES TWO NEW INDICATIONS FOR RITUXAN RITUXIMAB IN PATIENTS WITH NON HODGKINS LYMPHOMA The U.S. Food and Drug Administration FDA has approved two additional uses for Rituxan for patients with CD20 positive, B cell non Hodgkin's lymphoma NHL . One new indication for Rituxan is for first line treatment of previously untreated patients with follicular NHL in combination with CVP cyclophosphamide, vincristine and prednisolone chemotherapy. The second new indic...

FDA APPROVES TWO NEW INDICATIONS FOR RITUXAN RITUXIMAB IN PATIENTS WITH NON HODGKINS LYMPHOMA The U.S. Food and Drug Administration FDA has approved two additional uses for Rituxan for patients with CD20 positive, B cell non Hodgkin's lymphoma NHL . One new indication for Rituxan is for first line treatment of...

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE NODE POSITIVE BREAST CANCERGenentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval was based on data from an interim joint analysis of more than 3,500 patients enrolled in ...

2008 Rare Neuroimmunologic Disorders Symposium, Acute Therapies: Steroids, IVIG, Plasmaexchange and Cyclophosphamide, Benjamin M. Greenberg ...

FDA APPROVES TWO NEW INDICATIONS FOR RITUXAN RITUXIMAB IN PATIENTS WITH NON HODGKIN'S LYMPHOMAThe U.S. Food and Drug Administration FDA has approved two additional uses for Rituxan for patients with CD20 positive, B cell non Hodgkin's lymphoma NHL . One new indication for Rituxan is for first line treatment of previously untreated patients with follicular NHL in combination with CVP cyclophosphamide, vincristine and prednisolone chemotherapy. &c...

High Dose Cyclophosphamide: a cure for autoimmune disease?

2008 Rare Neuroimmunologic Disorders Symposium, High Dose Cyclophosphamide in Multiple Sclerosis, Chitra Krishnan, MHS, Adam I. Kaplin, MD, PhD